Erin Chui is an experienced finance professional currently serving as Associate Director at Akero Therapeutics since August 2025. Prior roles include Senior Manager of Financial Planning and Analysis at IDEAYA Biosciences, and Manager of Financial Planning and Analysis at Nektar Therapeutics. Erin's background also includes a position in Business Strategy Finance at Kaiser Permanente, and multiple roles in assurance and accounting at PwC, Novogradac & Company LLP, Shoreline Surgical, and DW Investment Group. Erin began a career in finance as a summer intern in Financial Advisory at UBS. Erin holds a Bachelor of Arts in Business Economics and Accounting from UC Irvine, complemented by a brief educational experience at the University of Sussex.
This person is not in the org chart
This person is not in any teams
This person is not in any offices